Zobrazeno 1 - 10
of 303
pro vyhledávání: '"Chun-Ming Tsai"'
Publikováno v:
Current Oncology, Vol 31, Iss 6, Pp 3161-3176 (2024)
Background: Advanced non-small-cell lung cancer (NSCLC) can be treated with novel targeted therapies that are tailored to the genetic characteristics of malignancy. While tissue-based genomic testing is considered the gold standard for the detection
Externí odkaz:
https://doaj.org/article/66c940d9e187447cb7f689667605b347
Autor:
Zhe-Rong Zheng, Hsiu-Ying Ku, Kun-Chieh Chen, Chun-Ju Chiang, Chih-Liang Wang, Chih-Yi Chen, Chun-Ming Tsai, Ming-Shyan Huang, Chong-Jen Yu, Jin-Shing Chen, Teh-Ying Chou, Wen-Chung Lee, Chun-Chieh Wang, Tsang-Wu Liu, Jiun-Yi Hsia, Gee-Chen Chang
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionAnaplastic lymphoma kinase (ALK) fusion mutation is more common in younger and never-smoking lung cancer patients. The association of smoking and ALK-tyrosine kinase inhibitors (TKIs) on overall survival (OS) of treatment-naïve ALK-posit
Externí odkaz:
https://doaj.org/article/c3b9b5884b7e45a08b99a9fcc2d49146
Autor:
Byoung Chul Cho, Herbert H. F. Loong, Chun-Ming Tsai, Man Lung P. Teo, Hye Ryun Kim, Sun Min Lim, Suyog Jain, Steve Olsen, Keunchil Park
Publikováno v:
Current Oncology, Vol 29, Iss 3, Pp 2154-2164 (2022)
Plasma-based next-generation sequencing (NGS) has demonstrated the potential to guide the personalized treatment of non-small cell lung cancer (NSCLC). Inherent differences in mutational genomic profiles of NSCLC exist between Asian and Western popul
Externí odkaz:
https://doaj.org/article/56e3c7bc762a4cb7a4d8412e5f4fef6d
Autor:
Hsiang-Ling Ho, Yuqiu Jiang, Chi-Lu Chiang, Sylwia Karwowska, Ranga Yerram, Keerti Sharma, Sidney Scudder, Chao-Hua Chiu, Chun-Ming Tsai, John F Palma, Abha Sharma, Teh-Ying Chou
Publikováno v:
PLoS ONE, Vol 17, Iss 4, p e0267362 (2022)
15-40% of non-small cell lung cancer (NSCLC) patients harbor epidermal growth factor receptor (EGFR)-sensitizing mutations. Tyrosine kinase inhibitors (TKIs) provide significant clinical benefit in this population, yet all patients will ultimately pr
Externí odkaz:
https://doaj.org/article/94a7cba9fb074383abb2b0bf1dd27b6d
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 19, p 11353 (2022)
Assessing tumor EGFR mutation status is necessary for the proper management of patients with advanced non–small cell lung cancer (NSCLC). We evaluated the impact of dynamic analyses of the plasma and tissue EGFR mutation using ultra-sensitive dropl
Externí odkaz:
https://doaj.org/article/180cf2b72b9444f7aef992f8dba869c4
Autor:
Daniel S.W. Tan, BSc, M.B.B.S., MRCP, PhD, Sarayut Geater, MD, Chong-Jen Yu, MD, PhD, Chun-Ming Tsai, MD, Te-Chun Hsia, MD, Jun Chen, MD, PhD, Meng-Chih Lin, MD, You Lu, MD, Virote Sriuranpong, MD, Cheng-Ta Yang, MD, Paramita Sen, PhD, Fabrice Branle, MD, Michael Shi, MD, Yi-Long Wu, MD
Publikováno v:
JTO Clinical and Research Reports, Vol 2, Iss 3, Pp 100131- (2021)
Introduction: In the phase 3 ASCEND-4 study, ceritinib exhibited improved progression-free survival (PFS) by Blinded Independent Review Committee (BIRC) assessment versus the standard first-line chemotherapy in patients with advanced ALK-rearranged N
Externí odkaz:
https://doaj.org/article/69d661b3bc784f2984f64d772eef3b48
Publikováno v:
SAGE Open, Vol 10 (2020)
Mobile devices are becoming ubiquitous methodologies and tools, providing application for learning and teaching field. On the basis of the widespread use of wireless devices and mobile computing technology, this study proposes a context-aware plant e
Externí odkaz:
https://doaj.org/article/0fdefbab4ecb4d2bafc76da69ad9c68e
Publikováno v:
Journal of Cancer Research and Practice, Vol 2, Iss 1, Pp 76-82 (2015)
The incidence of double primary malignancy in colorectal cancer is rare (approximately 1-6%), and synchronous double primary malignancy is even rarer for cases involving colorectal cancer. Indeed, its incidence is estimated to be less than 1%. The pr
Externí odkaz:
https://doaj.org/article/aea648671315455b9845e09f50026bf9
Autor:
Gee-Chen Chang, Chun-Ming Tsai, Te-Chun Hsia, Chih-Hsin Yang, Radhi Abdulnabi, Julie M. Blair, Carlos Linn
Publikováno v:
Journal of the Formosan Medical Association, Vol 112, Iss 9, Pp 518-526 (2013)
Although global and Asian studies on second-line pemetrexed for the treatment of advanced nonsmall cell lung cancer have confirmed its efficacy and safety, a pivotal postcommitment study to consolidate the evidence regarding the Taiwanese population
Externí odkaz:
https://doaj.org/article/998fc2e15a5249a2b6b141d70422ba59
Publikováno v:
Journal of the Formosan Medical Association, Vol 107, Iss 8, Pp 635-643 (2008)
Background/Purpose: To investigate the quality of care (QOC) for lung cancer in Taiwan, as measured by pattern of care (POC) variation. Methods: Based on core measures in the Taiwan Cancer Database (TCDB) registry, QOC for lung cancer was measured as
Externí odkaz:
https://doaj.org/article/845e2ba1cfac4d36a6c9564649b8c4e4